Methylphenidate hydrochloride en es it fr

Methylphenidate hydrochloride Brand names, Methylphenidate hydrochloride Analogs

Methylphenidate hydrochloride Brand Names Mixture

  • No information avaliable

Methylphenidate hydrochloride Chemical_Formula

C14H19NO2

Methylphenidate hydrochloride RX_link

http://www.rxlist.com/cgi/generic/methphen.htm

Methylphenidate hydrochloride fda sheet

Methylphenidate_hydrochloride FDA

Methylphenidate hydrochloride msds (material safety sheet)

Methylphenidate_hydrochloride MSDS

Methylphenidate hydrochloride Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Methylphenidate hydrochloride Molecular Weight

233.306 g/mol

Methylphenidate hydrochloride Melting Point

224-226oC

Methylphenidate hydrochloride H2O Solubility

1255mg/L

Methylphenidate hydrochloride State

Solid

Methylphenidate hydrochloride LogP

3.192

Methylphenidate hydrochloride Dosage Forms

Tablets; Tablets (sustained release)

Methylphenidate hydrochloride Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Methylphenidate hydrochloride Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Methylphenidate hydrochloride Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Methylphenidate hydrochloride side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Methylphenidate hydrochloride Patient Information

Methylphenidate hydrochloride Organisms Affected

Humans and other mammals